Towards Healthcare
Cell and Gene Therapy Logistics Market to Rise USD 4.33 Bn by 2034

Cell and Gene Therapy Logistics Market Driven by AI Growth

Based on market forecasts, the cell & gene therapy logistics sector will expand from USD 1.45 billion in 2024 to USD 4.33 billion by 2034, experiencing a CAGR of 11.54%. The cell & gene therapy logistics market is growing because it provides many benefits, such as maintaining efficacy and safety, ensuring regulatory compliance, supporting personalized medicine, and increasing the efficiency of operation. North America is dominant in the market due to increasing significant investment in R&D and a robust government framework.

Content

  • Insight Code: 6064
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The cell & gene therapy logistics market stands at USD 1.62 billion in 2025 and is expected to reach USD 4.33 billion by 2034, growing at a CAGR of 11.54% from 2024 to 2034.

North America is currently leading the cell & gene therapy logistics market due to its advanced infrastructure and concentration of many biotech companies.

The cell & gene therapy logistics market includes six segments such as by service type, by therapy type, by end user, by component, by deployment, and by region.

Key trends include an increased focus on personalized and sustainable solutions.

The Cell and Gene Therapy Facility is a manufacturing site for advanced therapy medicinal products (ATMPs) licensed by the Medicines and Healthcare products Regulatory Agency.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions